Securities Class Actions – Page 58 – ClaimsFiler

Case Type: Securities Class Actions

According to the Complaint, 2U is an education technology company that works with universities to provide
online graduate programs and certificates for working adults.

According to the Complaint, Carbonite is a software company that provides cloud-based backup services, including the Server Backup VM Edition for managed services providers ("MSPs"), which was designed to allow MSPs to protect their virtual data both locally and in their own cloud.

According to the Complaint, Aclaris is a biopharmaceutical company that identifies, develops, and commercializes therapies to address unmet needs in medical and aesthetic dermatology and immunology. Its lead product ESKATA is a hydrogen peroxide topical solution that is FDAapproved to treat raised seborrheic keratosis, a common non-malignant tumor.

According to the Complaint, Oasmia purports to be a pharmaceutical company focused on innovative treatments within human and animal oncology.

According to the Complaint, Eagle Bancorp operates as the bank holding company for EagleBank that provides commercial and consumer banking services primarily in the United States.

According to the Complaint, Ideanomics purports to operate as a fintech and asset digitization servicescompany. From June 2017 until August 2018, the Company was known as Seven Stars Cloud Group, Inc. and announced the adoption of Ideanomics as its new business name on August 27, 2018. From October 2016 until June 2017, the Company was known as Wecast Network Inc.

According to the Complaint, Verb purportedly operates as an applications services provider with cloud-based software products for businesses. As part of its business, Verb utilizes interactive videos as part of its customer relationship management application. Verb has formerly operated under the names of nFusz, Inc., bBooth, Inc., bBooth (USA), Inc., and Cutaia Media Group, LLC.

According to the Complaint, Acer is a pharmaceutical company that purportedly focuses on the acquisition, development, and commercialization of therapies for serious rare and life-threatening diseases. Acer's pipeline includes, inter alia, EDSIVO (celiprolol) for the treatment of vEDS in patients with a confirmed type III collagen mutation.

The Complaint alleges that Walgreens Boots Alliance, Inc., Fred's Inc. and certain of their respective officers issued false and misleading statements and/or failed to disclose, among other things, the level of regulatory risk faced by the original and revised mergers pursuant to which Walgreens would acquire Rite Aid Corp. Walgreens and Rite Aid had entered into an agreement with Fred's to sell 865 Rite Aid stores for $950 million in an all-cash transaction in order to complete the Original Merger (the "Fred's Asset Purchase Agreement"). On January 30, 2017, Rite Aid and Walgreens announced that they had entered into a new merger agreement (the "Revised Merger"). On June 29, 2017, Rite Aid and Walgreens announced that they had terminated the Revised Merger. Following the termination of the Revised Merger, Walgreens terminated the Fred's Asset Purchase Agreement.

According to the Complaint, Eros purports to be a leading company in the Indian film entertainment industry and to co-produce, acquire and distribute Indian language films in multiple formats worldwide. Eros is incorporated in the Isle of Man.

According to the Complaint, Zuora is a cloud-based subscription management platform. Its business consists of three components: Zuora Central Platform, a subscription management hub; order-to-revenue products; and an application marketplace. Its flagship products are RevPro, a revenue recognition automation solution that enables customers to group transactions into revenue contracts and performance obligations, and Billing, which is designed for subscription billing. Zuora acquired RevPro in May 2017 when it acquired Leeyo.

According to the Complaint, Mammoth Energy Services Inc. purports to operate as an oilfield service company operating in three segments: Infrastructure Services, Pressure Pumping Services, and Natural Sand Proppant
Services.

According to the Complaint, Ra Medical is a medical device company that purports to use its excimer laser-based platform for treatment of vascular and dermatological immunemediated inflammatory diseases.

We use cookies to improve your overall web experience. By using our website, you consent to the use of cookies in accordance with our Privacy Policy.

OK